163 related articles for article (PubMed ID: 37013637)
1. Expression signature and molecular basis of CDH11 in OSCC detected by a combination of multiple methods.
Wei Y; Cheng X; Deng L; Dong H; Wei H; Xie C; Tuo Y; Li G; Yu D; Cao Y
BMC Med Genomics; 2023 Apr; 16(1):70. PubMed ID: 37013637
[TBL] [Abstract][Full Text] [Related]
2. MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition.
Hsiao SY; Weng SM; Hsiao JR; Wu YY; Wu JE; Tung CH; Shen WL; Sun SF; Huang WT; Lin CY; Chen SH; Hong TM; Chen YL; Chang JY
J Exp Clin Cancer Res; 2023 Feb; 42(1):40. PubMed ID: 36737832
[TBL] [Abstract][Full Text] [Related]
3. FERMT1 knockdown inhibits oral squamous cell carcinoma cell epithelial-mesenchymal transition by inactivating the PI3K/AKT signaling pathway.
Wang X; Chen Q
BMC Oral Health; 2021 Nov; 21(1):598. PubMed ID: 34814915
[TBL] [Abstract][Full Text] [Related]
4. Combined overexpression of cadherin 6, cadherin 11 and cluster of differentiation 44 is associated with lymph node metastasis and poor prognosis in oral squamous cell carcinoma.
Ma C; Zhao JZ; Lin RT; Zhou L; Chen YN; Yu LJ; Shi TY; Wang M; Liu MM; Liu YR; Zhang T
Oncol Lett; 2018 Jun; 15(6):9498-9506. PubMed ID: 29805672
[TBL] [Abstract][Full Text] [Related]
5. Role of miR-218-GREM1 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma: An in vivo and vitro study based on microarray data.
Wang Y; Jiang Y; Chen L
J Cell Mol Med; 2020 Dec; 24(23):13824-13836. PubMed ID: 33107676
[TBL] [Abstract][Full Text] [Related]
6. Pituitary tumor-transforming gene 1 (PTTG1) is overexpressed in oral squamous cell carcinoma (OSCC) and promotes migration, invasion and epithelial-mesenchymal transition (EMT) in SCC15 cells.
Zhang E; Liu S; Xu Z; Huang S; Tan X; Sun C; Lu L
Tumour Biol; 2014 Sep; 35(9):8801-11. PubMed ID: 24879625
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis.
Li C; Li Q; Cai Y; He Y; Lan X; Wang W; Liu J; Wang S; Zhu G; Fan J; Zhou Y; Sun R
Cancer Gene Ther; 2016 Sep; 23(9):295-302. PubMed ID: 27492854
[TBL] [Abstract][Full Text] [Related]
8. Identification of Biological Functions and Prognostic Value of NNMT in Oral Squamous Cell Carcinoma.
Zhang W; Jing Y; Wang S; Wu Y; Sun Y; Zhuang J; Huang X; Chen S; Zhang X; Song Y; Hu Q; Ni Y
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291696
[TBL] [Abstract][Full Text] [Related]
9. Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma.
Sun Y; Wang S; Zhang X; Wu Z; Li Z; Ding Z; Huang X; Chen S; Jing Y; Zhang X; Ding L; Song Y; Sun G; Ni Y
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944486
[TBL] [Abstract][Full Text] [Related]
10. Elevated Expression of Zinc Finger Protein 703 Promotes Cell Proliferation and Metastasis through PI3K/AKT/GSK-3β Signalling in Oral Squamous Cell Carcinoma.
Wang H; Deng X; Zhang J; Ou Z; Mai J; Ding S; Huo S
Cell Physiol Biochem; 2017; 44(3):920-934. PubMed ID: 29176314
[TBL] [Abstract][Full Text] [Related]
11. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p.
Han L; Cheng J; Li A
Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508
[No Abstract] [Full Text] [Related]
12. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
13. FBXW7 inhibited cell proliferation and invasion regulated by miR-27a through PI3K/AKT signaling pathway and epithelial-to-mesenchymal transition in oral squamous cell carcinoma.
Li C; Lin XF; Wang JN; Ren XS
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3701-3709. PubMed ID: 32329846
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
[TBL] [Abstract][Full Text] [Related]
15. miR-146a promotes proliferation, invasion, and epithelial-to-mesenchymal transition in oral squamous carcinoma cells.
Wang F; Ye LJ; Wang FJ; Liu HF; Wang XL
Environ Toxicol; 2020 Oct; 35(10):1050-1057. PubMed ID: 32469461
[TBL] [Abstract][Full Text] [Related]
16. Spindle and kinetochore-associated complex 3 promotes cell growth via the PI3K/AKT/GSK3β and PI3K/AKT/FOXO1 pathways and is a potential prognostic biomarker for oral squamous cell carcinoma.
Xu H; Chen G; Niu Q; Song K; Feng Z; Han Z
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Nov; 134(5):599-614. PubMed ID: 36123287
[TBL] [Abstract][Full Text] [Related]
17. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
Guo H; Li C; Su X; Huang X
Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
[No Abstract] [Full Text] [Related]
18. TAB2 Promotes the Biological Functions of Head and Neck Squamous Cell Carcinoma Cells via EMT and PI3K Pathway.
Liu H; Zhang H; Fan H; Tang S; Weng J
Dis Markers; 2022; 2022():1217918. PubMed ID: 35978886
[TBL] [Abstract][Full Text] [Related]
19. Serine hydroxymethyltransferase 2 (SHMT2) potentiates the aggressive process of oral squamous cell carcinoma by binding to interleukin enhancer-binding factor 2 (ILF2).
Zhang H; Che Y; Xuan B; Wu X; Li H
Bioengineered; 2022 Apr; 13(4):8785-8797. PubMed ID: 35333683
[TBL] [Abstract][Full Text] [Related]
20. Long Noncoding RNA LEMD1-AS1 Increases LEMD1 Expression and Activates PI3K-AKT Pathway to Promote Metastasis in Oral Squamous Cell Carcinoma.
Li Z; Wang J; Wu J; Li N; Jiang C
Biomed Res Int; 2022; 2022():3543948. PubMed ID: 35983249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]